Product Code: ETC13169485 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Pulmonary Embolism Market was valued at USD 1.9 Billion in 2024 and is expected to reach USD 2.7 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).
The Global Pulmonary Embolism Market is experiencing significant growth due to the increasing prevalence of pulmonary embolism cases worldwide. Pulmonary embolism is a serious condition characterized by a blockage in one of the pulmonary arteries in the lungs, often caused by blood clots traveling from other parts of the body. Factors such as a sedentary lifestyle, obesity, and aging population contribute to the rising incidence of pulmonary embolism. The market is driven by advancements in diagnostic techniques, such as CT pulmonary angiography and ventilation-perfusion scanning, as well as innovative treatment options like anticoagulant medications and thrombolytic therapy. Key players in the market are focusing on developing novel therapies and devices to improve patient outcomes and reduce the risk of recurrent pulmonary embolism, thereby driving market growth.
The Global Pulmonary Embolism Market is experiencing significant growth due to an increasing prevalence of pulmonary embolism cases worldwide. The market is driven by advancements in diagnostic technologies, such as CT angiography and ventilation-perfusion scanning, leading to early detection and treatment. Additionally, the rising adoption of novel anticoagulant therapies and the development of targeted therapies are creating new opportunities for market growth. Telemedicine and remote monitoring solutions are also emerging trends, enabling better management of pulmonary embolism patients, particularly in underserved areas. With a focus on personalized medicine and precision healthcare, pharmaceutical companies and medical device manufacturers are investing in research and development to bring innovative products to the market, further driving the growth of the Global Pulmonary Embolism Market.
The Global Pulmonary Embolism Market faces several challenges, including limited awareness about the condition among the general population and healthcare professionals, leading to underdiagnosis and undertreatment. Additionally, the lack of specific diagnostic tools for early detection and varying treatment guidelines across different regions pose challenges in standardizing care. High treatment costs, especially for novel therapies and interventions, can also limit access to effective treatments for patients. Furthermore, the complex nature of pulmonary embolism, which can present with a wide range of symptoms and risk factors, requires a multidisciplinary approach for accurate diagnosis and management. Addressing these challenges will be crucial in improving outcomes for patients with pulmonary embolism and advancing the overall market for related therapeutics and diagnostics.
The global pulmonary embolism market is primarily driven by factors such as increasing prevalence of pulmonary embolism cases worldwide, growing awareness about the risk factors and symptoms of the condition, advancements in diagnostic technologies for early detection, and a rise in the aging population susceptible to pulmonary embolism. Additionally, the increasing adoption of anticoagulant therapies, ongoing research and development activities focused on innovative treatment options, and favorable reimbursement policies for pulmonary embolism treatments are also contributing to market growth. Furthermore, the rising healthcare expenditure and improving healthcare infrastructure in developing countries are expected to drive the market further in the coming years.
Government policies related to the Global Pulmonary Embolism Market focus on improving early diagnosis, treatment access, and overall patient outcomes. Initiatives include guidelines for healthcare providers on evidence-based practices, funding support for research on new treatment options, and efforts to enhance public awareness about pulmonary embolism risk factors and symptoms. Regulatory bodies also monitor the safety and efficacy of existing treatments, ensuring compliance with quality standards. Additionally, policies aim to promote collaboration between stakeholders such as healthcare professionals, pharmaceutical companies, and patient advocacy groups to address challenges in the pulmonary embolism landscape effectively. Overall, government policies strive to advance the care and management of pulmonary embolism patients through a comprehensive and coordinated approach.
The Global Pulmonary Embolism Market is poised for significant growth in the coming years due to the increasing prevalence of pulmonary embolism cases worldwide. Factors such as aging populations, rising obesity rates, and sedentary lifestyles contribute to the higher incidence of pulmonary embolism, driving the demand for effective diagnostic and treatment options. Technological advancements in imaging techniques and minimally invasive procedures are expected to further boost market growth. Additionally, the growing awareness about the condition and improved healthcare infrastructure in emerging economies are likely to create lucrative opportunities for market players. However, challenges such as high treatment costs and stringent regulatory requirements may hinder market expansion. Overall, the Global Pulmonary Embolism Market is forecasted to experience steady growth as the need for better management of this life-threatening condition continues to rise.
The global pulmonary embolism market shows varying trends across different regions. In Asia, the market is expected to witness significant growth due to the rising prevalence of risk factors such as obesity and sedentary lifestyles. North America holds a dominant position in the market, driven by advanced healthcare infrastructure and increasing awareness about pulmonary embolism. Europe also has a strong market presence, attributed to the high adoption of advanced diagnostic and treatment options. In the Middle East and Africa region, the market growth is moderate, influenced by improving healthcare facilities and increasing investments in healthcare infrastructure. Latin America is projected to show steady growth in the market, driven by the rising incidences of pulmonary embolism and improving access to healthcare services.
Global Pulmonary Embolism Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Pulmonary Embolism Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Pulmonary Embolism Market Revenues & Volume, 2021 & 2031F |
3.3 Global Pulmonary Embolism Market - Industry Life Cycle |
3.4 Global Pulmonary Embolism Market - Porter's Five Forces |
3.5 Global Pulmonary Embolism Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Pulmonary Embolism Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.7 Global Pulmonary Embolism Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Global Pulmonary Embolism Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.9 Global Pulmonary Embolism Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Global Pulmonary Embolism Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Pulmonary Embolism Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Pulmonary Embolism Market Trends |
6 Global Pulmonary Embolism Market, 2021 - 2031 |
6.1 Global Pulmonary Embolism Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Pulmonary Embolism Market, Revenues & Volume, By Shortness of Breath, 2021 - 2031 |
6.1.3 Global Pulmonary Embolism Market, Revenues & Volume, By Chest Pain, 2021 - 2031 |
6.1.4 Global Pulmonary Embolism Market, Revenues & Volume, By Cough, 2021 - 2031 |
6.1.5 Global Pulmonary Embolism Market, Revenues & Volume, By Irregular Heartbeat, 2021 - 2031 |
6.1.6 Global Pulmonary Embolism Market, Revenues & Volume, By Dizziness, 2021 - 2031 |
6.1.7 Global Pulmonary Embolism Market, Revenues & Volume, By Fever, 2021 - 2031 |
6.1.8 Global Pulmonary Embolism Market, Revenues & Volume, By Cyanosis, 2021 - 2031 |
6.2 Global Pulmonary Embolism Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Pulmonary Embolism Market, Revenues & Volume, By Chest X-Ray, 2021 - 2031 |
6.2.3 Global Pulmonary Embolism Market, Revenues & Volume, By ECG, 2021 - 2031 |
6.2.4 Global Pulmonary Embolism Market, Revenues & Volume, By MRI, 2021 - 2031 |
6.2.5 Global Pulmonary Embolism Market, Revenues & Volume, By CT Scan, 2021 - 2031 |
6.2.6 Global Pulmonary Embolism Market, Revenues & Volume, By Pulmonary Angiography, 2021 - 2031 |
6.2.7 Global Pulmonary Embolism Market, Revenues & Volume, By Venography, 2021 - 2031 |
6.2.8 Global Pulmonary Embolism Market, Revenues & Volume, By Venous Ultrasound, 2021 - 2031 |
6.2.9 Global Pulmonary Embolism Market, Revenues & Volume, By D-Dimer Test, 2021 - 2031 |
6.3 Global Pulmonary Embolism Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Pulmonary Embolism Market, Revenues & Volume, By Medications, 2021 - 2031 |
6.3.3 Global Pulmonary Embolism Market, Revenues & Volume, By Mechanical Devices, 2021 - 2031 |
6.3.4 Global Pulmonary Embolism Market, Revenues & Volume, By Surgery, 2021 - 2031 |
6.4 Global Pulmonary Embolism Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Pulmonary Embolism Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Pulmonary Embolism Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.4.4 Global Pulmonary Embolism Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.5 Global Pulmonary Embolism Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Pulmonary Embolism Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.5.3 Global Pulmonary Embolism Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.5.4 Global Pulmonary Embolism Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Pulmonary Embolism Market, Overview & Analysis |
7.1 North America Pulmonary Embolism Market Revenues & Volume, 2021 - 2031 |
7.2 North America Pulmonary Embolism Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Pulmonary Embolism Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
7.4 North America Pulmonary Embolism Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.5 North America Pulmonary Embolism Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.6 North America Pulmonary Embolism Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7 North America Pulmonary Embolism Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Pulmonary Embolism Market, Overview & Analysis |
8.1 Latin America (LATAM) Pulmonary Embolism Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Pulmonary Embolism Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Pulmonary Embolism Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
8.4 Latin America (LATAM) Pulmonary Embolism Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
8.5 Latin America (LATAM) Pulmonary Embolism Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.6 Latin America (LATAM) Pulmonary Embolism Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.7 Latin America (LATAM) Pulmonary Embolism Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Pulmonary Embolism Market, Overview & Analysis |
9.1 Asia Pulmonary Embolism Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Pulmonary Embolism Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Pulmonary Embolism Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
9.4 Asia Pulmonary Embolism Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
9.5 Asia Pulmonary Embolism Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.6 Asia Pulmonary Embolism Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.7 Asia Pulmonary Embolism Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Pulmonary Embolism Market, Overview & Analysis |
10.1 Africa Pulmonary Embolism Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Pulmonary Embolism Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Pulmonary Embolism Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
10.4 Africa Pulmonary Embolism Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
10.5 Africa Pulmonary Embolism Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.6 Africa Pulmonary Embolism Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.7 Africa Pulmonary Embolism Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Pulmonary Embolism Market, Overview & Analysis |
11.1 Europe Pulmonary Embolism Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Pulmonary Embolism Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Pulmonary Embolism Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
11.4 Europe Pulmonary Embolism Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
11.5 Europe Pulmonary Embolism Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.6 Europe Pulmonary Embolism Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.7 Europe Pulmonary Embolism Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Pulmonary Embolism Market, Overview & Analysis |
12.1 Middle East Pulmonary Embolism Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Pulmonary Embolism Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Pulmonary Embolism Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Pulmonary Embolism Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
12.4 Middle East Pulmonary Embolism Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
12.5 Middle East Pulmonary Embolism Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.6 Middle East Pulmonary Embolism Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.7 Middle East Pulmonary Embolism Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Pulmonary Embolism Market Key Performance Indicators |
14 Global Pulmonary Embolism Market - Export/Import By Countries Assessment |
15 Global Pulmonary Embolism Market - Opportunity Assessment |
15.1 Global Pulmonary Embolism Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Pulmonary Embolism Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
15.3 Global Pulmonary Embolism Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
15.4 Global Pulmonary Embolism Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.5 Global Pulmonary Embolism Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.6 Global Pulmonary Embolism Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Pulmonary Embolism Market - Competitive Landscape |
16.1 Global Pulmonary Embolism Market Revenue Share, By Companies, 2024 |
16.2 Global Pulmonary Embolism Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |